comparemela.com
4
5
6
7
8
9
10
Latest Breaking News On - Michael leuchten - Page 3 : comparemela.com
NOVO NORDISK : UBS remains a Sell rating
Michael Leuchten from UBS retains his negative opinion on the stock with a Sell rating. The target price continues to be set at DKK 720.
Michael-leuchten
Markets
BAYER AG : UBS reaffirms its Buy rating
In a research note, UBS analyst Michael Leuchten has maintained his recommendation on the stock with a Buy rating. The target price is unchanged at EUR 92.
Michael-leuchten
Markets
GSK plc (NYSE:GSK) Q2 2023 Earnings Call Transcript
Nick Stone: Hello, everyone. Welcome to our Half Year End Q2 2023 conference call webcast investors and analysts.
Japan
United-states
New-york
California
Germany
Delaware
China
Japanese
America
James-gordon
Peter-welford
Simon-baker
BAYER AG : Gets a Buy rating from UBS
Michael Leuchten from UBS retains his positive opinion on the stock with a Buy rating. The target price remains unchanged at EUR 92.
Michael-leuchten
Markets
Novartis AG (NYSE:NVS) Q2 2023 Earnings Call Transcript
Operator: Good morning and good afternoon and welcome to the Novartis Q2 2023 Results Release Conference Call and Live Webcast.
United-kingdom
Italy
Japan
Delaware
United-states
Germany
China
Millburn
Highland
Zaragoza
Baja-california
Mexico
vimarsana © 2020. All Rights Reserved.